Clinical Trials Logo

Vaping clinical trials

View clinical trials related to Vaping.

Filter by:

NCT ID: NCT04150510 Completed - Alcohol Drinking Clinical Trials

Assessment of Smoking, Vaping, and Alcohol Consumption Behavior

Start date: February 1, 2020
Phase:
Study type: Observational

To assess smoking, vaping, and alcohol consumption behaviors via online surveys in the population. Further, the objective is to administer additional surveys to assess which methods (e.g., pen-and-paper records, a smartphone app) for monitoring smoking, vaping, alcohol intake, and food intake are preferred by the study population.

NCT ID: NCT04054765 Completed - Vaping Clinical Trials

A Virtual Reality Videogame for E-cigarette Prevention in Teens

Start date: October 17, 2019
Phase: N/A
Study type: Interventional

The use of the Invite Only VR, with the aim to prevent the initiation of e-cigarette use in teens by increasing their knowledge, decreasing their intentions to use e-cigarettes, influencing their harm perceptions and attitudes associated with e-cigarettes, and increasing self-efficacy associated with refusing peers involving e-cigarettes.

NCT ID: NCT04053868 Completed - Tobacco Smoking Clinical Trials

Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes

Start date: December 9, 2019
Phase: N/A
Study type: Interventional

This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.

NCT ID: NCT03379740 Completed - Vaping Clinical Trials

Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

Start date: July 11, 2017
Phase: N/A
Study type: Interventional

This is a single-center, open-label, concentration-ranging study to evaluate the nicotine PK profile and PD effects in healthy adult experienced users of closed tank/cartridge e-cigarettes using four different variants of P4M3 (nicotine concentration of 1.7%, 1.7% with 1.1% lactic acid [LA], 3% with 1.1% LA, and 4% with 2% LA) or their own e-cigarettes.